Intravitreal chemotherapy in the management of vitreous disease in retinoblastoma


KIRATLI H., KOÇ İ., VARAN A., AKYÜZ C.

EUROPEAN JOURNAL OF OPHTHALMOLOGY, vol.27, no.4, pp.423-427, 2017 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 27 Issue: 4
  • Publication Date: 2017
  • Doi Number: 10.5301/ejo.5000921
  • Journal Name: EUROPEAN JOURNAL OF OPHTHALMOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.423-427

Abstract

Purpose: To evaluate the therapeutic outcome of intravitreal melphalan injection in the management of vitreous disease in patients with retinoblastoma. We particularly aimed to assess whether higher melphalan dose with lower number of injections was more effective and associated with fewer side effects.